Jaguar Health (JAGX) Competitors $12.98 +1.11 (+9.35%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$12.51 -0.47 (-3.62%) As of 05/2/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock JAGX vs. ALXO, TPST, GDTC, CLNN, BCAB, CGTX, DARE, CVM, GRCE, and CASIShould you be buying Jaguar Health stock or one of its competitors? The main competitors of Jaguar Health include ALX Oncology (ALXO), Tempest Therapeutics (TPST), CytoMed Therapeutics (GDTC), Clene (CLNN), BioAtla (BCAB), Cognition Therapeutics (CGTX), Daré Bioscience (DARE), CEL-SCI (CVM), Grace Therapeutics (GRCE), and CASI Pharmaceuticals (CASI). These companies are all part of the "pharmaceutical products" industry. Jaguar Health vs. ALX Oncology Tempest Therapeutics CytoMed Therapeutics Clene BioAtla Cognition Therapeutics Daré Bioscience CEL-SCI Grace Therapeutics CASI Pharmaceuticals ALX Oncology (NASDAQ:ALXO) and Jaguar Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings, community ranking and analyst recommendations. Do analysts rate ALXO or JAGX? ALX Oncology currently has a consensus target price of $4.14, suggesting a potential upside of 676.88%. Given ALX Oncology's stronger consensus rating and higher probable upside, research analysts plainly believe ALX Oncology is more favorable than Jaguar Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ALX Oncology 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71Jaguar Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community prefer ALXO or JAGX? Jaguar Health received 1780 more outperform votes than ALX Oncology when rated by MarketBeat users. Likewise, 88.65% of users gave Jaguar Health an outperform vote while only 64.71% of users gave ALX Oncology an outperform vote. CompanyUnderperformOutperformALX OncologyOutperform Votes5564.71% Underperform Votes3035.29% Jaguar HealthOutperform Votes183588.65% Underperform Votes23511.35% Do insiders and institutionals have more ownership in ALXO or JAGX? 98.0% of ALX Oncology shares are held by institutional investors. Comparatively, 12.0% of Jaguar Health shares are held by institutional investors. 33.4% of ALX Oncology shares are held by insiders. Comparatively, 0.4% of Jaguar Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to ALXO or JAGX? In the previous week, ALX Oncology had 7 more articles in the media than Jaguar Health. MarketBeat recorded 7 mentions for ALX Oncology and 0 mentions for Jaguar Health. Jaguar Health's average media sentiment score of 0.31 beat ALX Oncology's score of -0.26 indicating that Jaguar Health is being referred to more favorably in the news media. Company Overall Sentiment ALX Oncology Neutral Jaguar Health Neutral Is ALXO or JAGX more profitable? ALX Oncology has a net margin of 0.00% compared to Jaguar Health's net margin of -360.13%. ALX Oncology's return on equity of -93.02% beat Jaguar Health's return on equity.Company Net Margins Return on Equity Return on Assets ALX OncologyN/A -93.02% -70.67% Jaguar Health -360.13%-326.62%-67.02% Which has better earnings and valuation, ALXO or JAGX? Jaguar Health has higher revenue and earnings than ALX Oncology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioALX OncologyN/AN/A-$160.80M-$2.60-0.20Jaguar Health$11.69M0.75-$41.30MN/AN/A Which has more risk & volatility, ALXO or JAGX? ALX Oncology has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500. Comparatively, Jaguar Health has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500. SummaryALX Oncology beats Jaguar Health on 9 of the 15 factors compared between the two stocks. Get Jaguar Health News Delivered to You Automatically Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JAGX vs. The Competition Export to ExcelMetricJaguar HealthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.75M$6.85B$5.56B$8.04BDividend YieldN/A2.95%5.09%4.22%P/E RatioN/A7.4422.6918.83Price / Sales0.75257.63404.28106.72Price / CashN/A65.8538.1834.62Price / Book3.236.576.794.33Net Income-$41.30M$143.14M$3.22B$247.97M7 Day Performance18.97%3.48%3.37%3.18%1 Month Performance185.27%10.49%6.95%8.13%1 Year Performance-97.28%-3.31%16.13%5.01% Jaguar Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JAGXJaguar Health0.126 of 5 stars$12.98+9.4%N/A-97.0%$8.75M$11.69M0.0050ALXOALX Oncology2.5705 of 5 stars$0.53-2.1%$4.14+680.7%-96.8%$28.32MN/A-0.1840Upcoming EarningsTPSTTempest Therapeutics2.0317 of 5 stars$7.83+0.9%$30.00+283.1%-84.8%$27.55MN/A-5.1220Upcoming EarningsGDTCCytoMed Therapeutics2.1716 of 5 stars$2.41+5.7%$5.00+107.5%+11.0%$26.37MN/A0.00N/AGap DownCLNNClene3.0669 of 5 stars$3.03+1.0%$50.20+1,556.8%-65.9%$26.05M$342,000.00-0.57100Upcoming EarningsBCABBioAtla2.9313 of 5 stars$0.44+1.0%$6.00+1,248.6%-82.3%$25.98M$11M-0.2660Upcoming EarningsNews CoverageCGTXCognition Therapeutics3.6716 of 5 stars$0.42-4.9%$7.13+1,610.7%-77.5%$25.81MN/A-0.4320Upcoming EarningsShort Interest ↓News CoveragePositive NewsDAREDaré Bioscience2.167 of 5 stars$2.89-3.0%$24.00+730.4%-20.4%$25.58M$9,784.00-4.8930Short Interest ↓Positive NewsCVMCEL-SCIN/A$0.30+4.6%N/A-83.0%$25.57MN/A-0.6343Analyst ForecastNews CoverageGRCEGrace Therapeutics2.7971 of 5 stars$2.51+0.8%$12.00+378.1%N/A$25.45MN/A-2.16N/AAnalyst ForecastNews CoveragePositive NewsGap DownCASICASI Pharmaceuticals3.9556 of 5 stars$2.03-1.0%$4.00+97.0%-27.2%$24.97M$28.54M-0.91180Positive News Related Companies and Tools Related Companies ALXO Alternatives TPST Alternatives GDTC Alternatives CLNN Alternatives BCAB Alternatives CGTX Alternatives DARE Alternatives CVM Alternatives GRCE Alternatives CASI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JAGX) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaguar Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jaguar Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy JAGX Stock Free JAGX Stock Alerts